WASHINGTON, DC—Patients with angina but no obstructive coronary artery disease (ANOCA) see no reduction in coronary vasomotor dysfunction when taking the calcium channel blocker diltiazem, data from ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈